ZANNI, MANUELA
 Distribuzione geografica
Continente #
EU - Europa 1.051
NA - Nord America 891
AS - Asia 480
SA - Sud America 44
AF - Africa 20
OC - Oceania 20
Totale 2.506
Nazione #
US - Stati Uniti d'America 866
DE - Germania 282
IT - Italia 273
CN - Cina 203
JP - Giappone 105
AT - Austria 81
IE - Irlanda 73
SE - Svezia 63
GB - Regno Unito 52
FR - Francia 46
TR - Turchia 39
FI - Finlandia 33
KR - Corea 32
UA - Ucraina 32
ES - Italia 25
HK - Hong Kong 22
BR - Brasile 19
IN - India 18
AU - Australia 17
NL - Olanda 17
SG - Singapore 15
CA - Canada 14
GR - Grecia 13
NO - Norvegia 12
PL - Polonia 12
SN - Senegal 12
PE - Perù 10
TW - Taiwan 10
PK - Pakistan 9
CH - Svizzera 8
CL - Cile 8
MX - Messico 8
BE - Belgio 7
PT - Portogallo 6
MY - Malesia 4
TH - Thailandia 4
DK - Danimarca 3
EC - Ecuador 3
IL - Israele 3
NZ - Nuova Zelanda 3
RO - Romania 3
RS - Serbia 3
RU - Federazione Russa 3
VN - Vietnam 3
AR - Argentina 2
BH - Bahrain 2
CO - Colombia 2
DZ - Algeria 2
ID - Indonesia 2
IR - Iran 2
MA - Marocco 2
PH - Filippine 2
PR - Porto Rico 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
Totale 2.506
Città #
Chandler 159
Beijing 114
Vienna 80
Dublin 71
Ashburn 41
Nyköping 35
Ann Arbor 32
Jacksonville 29
Dearborn 27
Medford 26
Rome 25
Houston 24
Princeton 22
Milan 20
Nürnberg 18
Ankara 17
Fairfield 17
Torino 17
Villeurbanne 17
Washington 16
Wilmington 16
Woodbridge 16
San Mateo 15
Shanghai 14
Atlanta 13
Central 13
Valdagno 13
Newburyport 12
Oslo 12
Florence 11
Tokyo 11
Warsaw 11
Madrid 10
Singapore 10
Toronto 10
Lima 9
Liverpool 9
Turin 9
Nagareyama 8
Palermo 8
Sydney 8
Boston 7
Cambridge 7
Chennai 7
Chicago 7
Guiyang 7
Berlin 6
Haveli Lakha 6
Kaohsiung City 6
Melbourne 6
Redwood City 6
Seattle 6
Belo Horizonte 5
Bologna 5
Brussels 5
Chengdu 5
Genoa 5
Guangzhou 5
Hirabari 5
Izmir 5
London 5
Nanjing 5
New York 5
Padova 5
Santiago 5
Toyoake 5
Udine 5
Varallo Pombia 5
Amsterdam 4
Boardman 4
Caen 4
Edinburgh 4
Frankfurt am Main 4
Fremont 4
Hebei 4
Helsinki 4
Jinan 4
Kuala Lumpur 4
Los Angeles 4
Monza 4
Orio Canavese 4
Philadelphia 4
Pisa 4
Reggio Emilia 4
Salerno 4
San Sebastián de los Reyes 4
Trieste 4
Wŏnju 4
Akishima 3
Antibes 3
Barcelona 3
Belgrade 3
Bengaluru 3
Brescia 3
Bucharest 3
Burgos 3
Casavatore 3
Chongqing 3
College Station 3
Dong Ket 3
Totale 1.312
Nome #
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi 899
High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) 140
Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis 121
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment. 120
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 110
Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients 103
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom 97
Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients 89
Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis? 85
The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation 84
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome 83
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 73
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL) 73
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma 71
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL) 70
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 68
null 64
Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial 56
Randomized trial comparing R-CHOP versus high-dose sequential chemotherapy in high-risk patients with diffuse large B-cell lymphomas 56
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial 42
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase III trial in mantle cell lymphoma 40
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 16
Totale 2.560
Categoria #
all - tutte 5.706
article - articoli 0
book - libri 0
conference - conferenze 1.998
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201959 0 0 0 0 0 0 0 0 0 18 26 15
2019/2020219 10 6 6 26 7 30 49 17 22 23 18 5
2020/2021157 23 7 9 5 10 3 13 4 12 30 21 20
2021/2022207 11 1 6 8 2 2 30 3 3 17 69 55
2022/2023754 58 48 35 57 57 125 67 59 79 52 44 73
2023/2024667 72 91 58 39 112 98 64 77 10 46 0 0
Totale 2.560